Correction to: Neuropsychopharmacology advance online publication, 27 September 2017; doi: https://doi.org/10.1038/npp.2017.205
This article was originally published under NPG's License to Publish, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the paper have been modified accordingly.
Additional information
The online version of the original article can be found at https://doi.org/10.1038/npp.2017.205
Rights and permissions
About this article
Cite this article
Reed, B., Butelman, E., Fry, R. et al. Erratum: Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence. Neuropsychopharmacol. 43, 928 (2018). https://doi.org/10.1038/npp.2017.245
Published:
Issue Date:
DOI: https://doi.org/10.1038/npp.2017.245
This article is cited by
-
The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male mice
Psychopharmacology (2020)
-
Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat
Psychopharmacology (2020)
